Vensana Capital unveils AI-powered intravascular ultrasound maker Evident Vascular
Fierce Biotech | Andrea Park
Intravascular ultrasound tech developer Evident Vascular exits stealth mode with $35M Series A
Mass Device | Sean Whooley
Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Intravascular Imaging Platform
Evident Vascular™ Inc., a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced today that it has launched with a $35 million Series A financing from Vensana Capital.